Acquired Tick Resistance in Naturally Exposed Participants
TICK REACT
The Uninfected Ixodes Scapularis Human Tick Challenge Model - Acquired Tick Resistance in Naturally Exposed Participants
1 other identifier
interventional
24
1 country
1
Brief Summary
Tick-borne diseases are increasing worldwide, and there are currently few effective ways to prevent them. One promising new strategy is to develop a vaccine that targets the tick itself ("anti-tick vaccine") to block the transmission of multiple pathogens. Some animals naturally develop resistance to ticks after repeated tick bites. There are indications that a similar form of acquired tick resistance (ATR) may also occur in humans who have been heavily exposed to ticks. This study investigates whether humans can naturally develop tick resistance and how this affects tick feeding. The investigators will compare people with a long history of tick bites and self-reported signs of tick resistance to people who are tick-naïve. The investigators will also include a small group of volunteers who previously participated in an experimental human tick challenge to evaluate what their reaction on tickbites is 1-2 years after their initial exposures.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Aug 2025
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
August 14, 2025
CompletedFirst Submitted
Initial submission to the registry
December 3, 2025
CompletedFirst Posted
Study publicly available on registry
March 18, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 1, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2026
ExpectedMarch 18, 2026
March 1, 2026
8 months
December 3, 2025
March 15, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Tick feeding: tick weight
Tick weight measured in mg after complete feeding of the tick
From the start of the tick challenge until feeding to repletion of the ticks (max 10 days)
Secondary Outcomes (5)
Tick feeding: tick mortality
From the start of the tick challenge until feeding to repletion of the ticks (max 10 days)
Host reaction: redness
Redness will be monitored at day 2 and the last day of the tick challenge
Host reaction: itch
Itch is measures daily during the tick challenge (From the start of the tick challenge until feeding to repletion of the ticks (max 10 days)
Host immune response: humoral
From the start of the challenge, day 2, day 5, final day of challenge (day 5-10) depending upon tick feeding, 3-5 weeks after the challenge and 10-12 weeks after the challenge
Host immune response: cellular
From the start of the challenge, day 2, day 5, final day of challenge (day 5-10) depending upon tick feeding, 3-5 weeks after the challenge and 10-12 weeks after the challenge
Study Arms (3)
Tick naive individuals
EXPERIMENTALIndividuals who have never been bitten by ticks before (as far as known)
Supposed tick immune individuals
EXPERIMENTALIndividuals who have been bitten by a lot of ticks before and experience a local reaction after each tickbite.
Previous TICK ME participants
EXPERIMENTALIndividuals who have participated in the TICK ME study
Interventions
uninfected ixodes scapularis ticks will be placed underneath a closed dressing
Eligibility Criteria
You may qualify if:
- Naturally acquired self-reported tick resistant individuals:
- Age: 18 - 70 years;
- History of repeated tick bites
- Local reaction (like redness or itch) at place of previous tick bites and/or signs of impaired tick feeding after bite (anamnestic)
- Controls:
- Age: 18 years - 70 years;
- Experimentally acquired tick resistant individuals:
- Previous participant in the TICK ME study that has completed all 4 challenges
- Age: 18 years - 70 years;
You may not qualify if:
- Current suspicion of any tick-borne disease
- Diagnosed with tick-borne disease within the last year
- Chronic skin condition affecting the skin of the arm;
- Inability to maintain the dressing for any reason;
- Known immunodeficiency or autoimmune disease;
- Use of systemic immunomodulating drugs or chemotherapy, current or in the past;
- Chronic use of antibiotics;
- Unable to give informed consent or do not have a thorough command of the Dutch language;
- Refusal to participate in specimen collection and storage for future study related use;
- Pregnant or breastfeeding women;
- Not willing to use adequate contraception during the study period;
- Red meat allergy (both medically confirmed and self-reported);
- Use of investigational therapy and devices during the time of the study;
- Any other condition that, in the opinion of the investigator, would make the patient unsuitable for enrolment or could interfere with the patient participating in and completing the study.
- Known history of tick bites;
- +5 more criteria
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Amsterdam UMC
Amsterdam, North Holland, 1105AZ, Netherlands
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Joppe W Hovius, Prof. Dr.
Amsterdam UMC
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- BASIC SCIENCE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- prof. dr.
Study Record Dates
First Submitted
December 3, 2025
First Posted
March 18, 2026
Study Start
August 14, 2025
Primary Completion
April 1, 2026
Study Completion (Estimated)
June 1, 2026
Last Updated
March 18, 2026
Record last verified: 2026-03